All posts by student

Postgraduate Biochemistry & Molecular Biology | Degrees …

Why study Biochemistry and molecular biology?

Our postgraduate biochemistry and molecular biology program has options for a variety of career paths and study interests. We offer advanced training in biotechnology and molecular biology at Masters-level. We also provide laboratory-based training including data management and a research-based component that is a pathway to PhD studies. We have an extensive PhD program where students are supervised by world leading research staff in state-of- the art laboratories.

The strength in research in this area is demonstrated by the 2012 Excellence in Research for Australia (ERA) ratings. In Biochemistry and Cell Biology, La Trobe was one of only two universities whose research output was rated well above world standard (achieving the maximum score of 5).

Students have access to some of the best teaching and research facilities in the world with the La Trobe Institute for Molecular Science (LIMS) building. LIMS focuses on training researchers to turn molecular science, biotechnology and nanotechnology research into medical solutions.

See the Research tab for information about Master's by research, or PhD.

As a La Trobe graduate you may be eligible for our 10% Alumni Advantage when you apply for a full-fee postgraduate coursework program.

Graduates are prepared for careers in many aspects related to biomedical research, molecular cell biology and biotechnology.

NB: The ATARs published here are a guide, based on the most recent intake, and can change from year to year. These are Clearly-in ATARs, meaning applicants with scores equivalent to, or higher than the quoted ATAR, were made an offer.

To find out more about this course and studying at La Trobe: - ask us a question - book a one-on-one consultation - chat online - visit our FAQ page - connect with us on Facebook, Twitter or Instagram - call us on 1300 135 045.

A limited number of La Trobe College Excellence Scholarships are available, offering up to 25% reduction on your postgraduate course fees. Learn More

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

Our highly-regarded course offers hands-on, technique-intensive learning, with a strong research focus aimed to equip you with the skills necessary to work in the sector. The curriculum covers key elements of biotechnology and the manipulation of molecular biological data.

The course offers you the opportunity to carry out a full year of laboratory-based research and participate in multiple weekly practicals. You'll spend between 25 and 30 hours in the lab each week during your second year.

Biotechnology is becoming increasingly central to a variety of industries, including medicine, diagnostics, agriculture, environmental protection, food technology and renewable resources technology. When you graduate you'll be prepared for work in molecular biology, biochemistry, bioinformatics and biotechnology, in business and research throughout the world.

Our graduates are working as biotechnologists and technicians at DTS Food Laboratories and Clonal Solutions Australia. They're also working as R and D scientists at biopharmaceutical company CSL Biotherapies and CSIRO. Many of our graduates go on to do further research and work as academics.

You'll also have the flexibility to exit with a Graduate Diploma in Biotechnology and Bioinformatics after completing the first year. If you are an international student and decide to go on to complete a PhD you may be eligible for a scholarship that covers your course fee.

To find out more about this course and studying at La Trobe: - ask us a question - book a one-on-one consultation - chat online - visit our FAQ page - connect with us on Facebook, Twitter or Instagram - call us on 1300 135 045.

A limited number of La Trobe College Excellence Scholarships are available, offering up to 25% reduction on your postgraduate course fees. Learn More

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

Methods of application vary from course to course. Please see the course entry above for details of how to apply for the course you are interested in.

Some postgraduate courses are fee-paying which means that you pay the full cost of the course (FEE-HELP is available). Others offer Commonwealth Supported Places (CSP) where the Commonwealth Government subsidises the cost of your course and you pay a contribution (HECS-HELP is available).

Students enrolled for certain postgraduate coursework programs may be eligible for student income support.

TOEFL Paper-based Test: minimum score of 575 (minimum score of 5 in the Test of Written English).

TOEFL Internet-based Test: minimum score of 80 with minimum overall for SLR 18; W 22.

La Trobe Melbourne (ELICOS): Completion of the English for Further Studies Advanced Stage 6B at La Trobe Melbourne with minimum 60 per cent overall and 60 per cent in final exam. For more information please visit the La Trobe Melbourne website.

English as the language of instruction in tertiary studies may be accepted. Please note: English as the language of instruction in previous study will not be accepted as a basis of admission (English) for courses where the approved test score requirement is above an IELTS 6.5 with no band score lower than 6.0.

Pearson Test of English (Academic) (PTE): minimum score of 64 with no communicative skill score less than 59.

Cambridge Certificate of Advanced English (CAE): a grade of B or higher.

Cambridge Certificate of Proficiency in English (CPE): a grade of C or higher.

Or approved international equivalent.

A limited number of La Trobe College Excellence Scholarships are available, offering up to 25% reduction on your postgraduate course fees. Learn More

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

Our highly-regarded course offers hands-on, technique-intensive learning, with a strong research focus aimed to equip you with the skills necessary to work in the sector. The curriculum covers key elements of biotechnology and the manipulation of molecular biological data.

The course offers you the opportunity to carry out a full year of laboratory-based research and participate in multiple weekly practicals. You'll spend between 25 and 30 hours in the lab each week during your second year.

Biotechnology is becoming increasingly central to a variety of industries, including medicine, diagnostics, agriculture, environmental protection, food technology and renewable resources technology. When you graduate you'll be prepared for work in molecular biology, biochemistry, bioinformatics and biotechnology, in business and research throughout the world.

Our graduates are working as biotechnologists and technicians at DTS Food Laboratories and Clonal Solutions Australia. They're also working as R and D scientists at biopharmaceutical company CSL Biotherapies and CSIRO. Many of our graduates go on to do further research and work as academics.

You'll also have the flexibility to exit with a Graduate Diploma in Biotechnology and Bioinformatics after completing the first year. If you are an international student and decide to go on to complete a PhD you may be eligible for a scholarship that covers your course fee.

TOEFL Paper-based Test: minimum score of 575 (minimum score of 5 in the Test of Written English).

TOEFL Internet-based Test: minimum score of 80 with minimum overall for SLR 18; W 22.

La Trobe Melbourne (ELICOS): Completion of the English for Further Studies Advanced Stage 6B at La Trobe Melbourne with minimum 60 per cent overall and 60 per cent in final exam. For more information please visit the La Trobe Melbourne website.

English as the language of instruction in tertiary studies may be accepted. Please note: English as the language of instruction in previous study will not be accepted as a basis of admission (English) for courses where the approved test score requirement is above an IELTS 6.5 with no band score lower than 6.0.

Pearson Test of English (Academic) (PTE): minimum score of 64 with no communicative skill score less than 59.

Cambridge Certificate of Advanced English (CAE): a grade of B or higher.

Cambridge Certificate of Proficiency in English (CPE): a grade of C or higher.

Or approved international equivalent.

A limited number of La Trobe College Excellence Scholarships are available, offering up to 25% reduction on your postgraduate course fees. Learn More

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

Enquire now about any course for international students or find out how to apply.

Estimated fees for international students are indicated for each course above. Fees are indicative only and set at 120 credit points per course, unless otherwise stated, and may vary depending on the number of credit points in which students enrol. Some courses may vary in credit point load and fees will be adjusted accordingly.

There is also a range of scholarships available for international students to assist students.

As a La Trobe student, you can broaden your horizons by studying overseas with one of our global exchange partners. We have partnerships with more than 100 universities in over 30 countries throughout Asia, Europe and North and South America.

You'll get to meet a large number of academic staff during your studies, from tutors through to lecturers and supervisors. View staff in Biochemistry and molecular biology.

Originally posted here:
Postgraduate Biochemistry & Molecular Biology | Degrees ...

Biochemistry and molecular biology – La Trobe University

We can help

There's a lot to consider when choosing your course.

You can also get updates on our courses and upcoming events via email.

Register now

Biochemistry and molecular biology are where biology and chemistry meet.

Study cell and molecular biology, disease, cell death and ageing, immunology, biotechnology, DNA and protein chemistry, metabolism and drug and vaccine development. Our courses have lots of practical training and field trips.

Biochemistry and molecular biology can be taken as a major in the Bachelor of Bioscience or studied as part of manyother science degrees.

Students have access to some of the best teaching and research facilities in the world with the completion of the new $100 million LaTrobe Institute for Molecular Science (LIMS) building.

You will be prepared for a career in many areas related to biomedical research, molecular cell biology and biotechnology.

Our students find work in government organisations, research institutes and private industry.

NB: The ATARs published here are a guide, based on the most recent intake, and can change from year to year. These are Clearly-in ATARs, meaning applicants with scores equivalent to, or higher than the quoted ATAR, were made an offer.

In the first year of this degree, you'll explore the basics of animal, plant and microbial biology through the lenses of cell biology, genetics, evolution, biodiversity and ecology. In second and third year, you can specialise through a choice of majors including botany, microbiology, zoology, biochemistry or genetics.

You'll get plenty of hands-on experience in our labs or on field trips to diverse habitats across Victoria. You'll be exposed to cutting edge biological research via world-class research institutes (the La Trobe Institute of Molecular Science and Centre for AgriBiosciences) and you'll have access to the La Trobe Wildlife Sanctuary on our Melbourne Campus.

During your field excursions you'll learn techniques to survey animal and plant biodiversity. During lab classes you'll gain the skills to conduct scientific experiments and develop and present your own work.

Along with practical and theoretical classes, we'll help you prepare for the workplace through opportunities for paid work experience.

If you intend to apply only to La Trobe you can apply direct to the University until applications close in December. Late direct applications may be accepted.

Please note: VTAC applications cannot be withdrawn in order to submit a direct application. The same selection criteria and entry standards are applied to VTAC and direct applications.

To find out more about this course and studying at La Trobe: - ask us a question - chat online - visit our FAQ page - connect with us on Facebook, Twitter or Instagram - call us on 1300 135 045.

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

First year foundational science subjects focus on biology and chemistry. Second year subjects - biosciences, medical science, biochemistry, genetics, anatomy, physiology and microbiology - will lead you towards your third year specialisation and postgraduate studies.

You'll learn about the human body in health and sickness, and gain knowledge of medical biochemistry, microbiology, pharmacology, cell and molecular biology, anatomy, physiology, infectious diseases and neuroscience.

You'll discover the symptoms of disease, learn how to analyse scientific and medical data, and do practical lab work. Third year advanced biochemistry and medical sciences internships and lab courses give you more hands-on experience. We'll also show you how to read, research and interpret scientific publications and teach you to meaningfully convey scientific and biomedical science information in writing.

Through this degree, you'll have access to the La Trobe Institute for Molecular Science - our $100 million teaching and research facility. With our industry cadetship program, you can also gain workplace experience, building on your skills and industry connections.

First year students may be eligible for the Dean's Scholarship for Academic Excellence or other undergraduate scholarships. We also offer overseas study opportunities, including clinical placements and volunteering.

You can apply to study this course through our Hallmark Scholars Program. See the listing for Hallmark Course Group C for more details.

NB: Meeting minimum prerequisites does not guarantee an offer of a place. Entry into all La Trobe courses is based on competitive selection and there may be limited places available.

Selection may also be based on GPA or STAT Multiple Choice.

If you intend to apply only to La Trobe you can apply direct to the University until applications close in December. Late direct applications may be accepted.

Please note: VTAC applications cannot be withdrawn in order to submit a direct application. The same selection criteria and entry standards are applied to VTAC and direct applications.

To find out more about this course and studying at La Trobe: - ask us a question - book a one-on-one consultation - chat online - visit our FAQ page - connect with us on Facebook, Twitter or Instagram - call us on 1300 135 045.

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

Our law degree has a strong focus on global and social justice. You'll study the essential legal areas like criminal law, constitutional law and legal ethics. You'll also cover science-related topics such as intellectual property and medicine and the law. Visiting lecturers from high profile law firms will help you develop an understanding of dispute resolution and recent legal developments.

You'll have the opportunity to participate in additional studies including Honours in Laws, subjects from our Global Business Law program at the Master's level, and clinical practice in a law firm.

The science component of this degree can be tailored to your interests. Choose from a range of specialisations including botany, computer science, psychology, chemistry and physics, and get hands-on experience through lab studies and field trips.

Only the first two years of this course are offered in Bendigo. While it is possible to arrange long-distance learning, we recommend transferring to the Melbourne Campus to complete your degree with a wider selection of subjects. Law electives are also available in intensive delivery at Melbourne in summer and winter schools.

If you intend to apply only to La Trobe you can apply direct to the University until applications close in December. Late direct applications may be accepted.

Please note: VTAC applications cannot be withdrawn in order to submit a direct application. The same selection criteria and entry standards are applied to VTAC and direct applications.

To find out more about this course and studying at La Trobe: - ask us a question - chat online - visit our FAQ page - connect with us on Facebook, Twitter or Instagram - call us on 1300 135 045.

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

This is one of our most flexible degrees with up to 18 specialist areas to choose from including agricultural science, biochemistry, biomedical science, botany, chemistry, computer science, electronics, environmental geoscience, genetics, information technology, mathematics, nanotechnology, statistics, microbiology, physics, psychology and zoology.

During your first two years, you'll study a range of introductory subjects to give you a solid foundation in science and related disciplines. Students enrolled at our Albury-Wodonga Campus will transfer to Melbourne or Bendigo after completing first year.

In third year, you'll either select two science specialties or combine your science major with studies from another discipline, like business or engineering.

Throughout your course, you'll have access to purpose-built facilities including the La Trobe Institute for Molecular Science. You'll also have opportunities for work placements with organisations like the Department of Environment and Primary Industries and other businesses conducting research in biochemistry, chemistry and genetics.

Through our partnerships with education providers all over the world, you'll also have the opportunity to study abroad and gain knowledge of alternative scientific processes and practices.

You can apply to study this course at Bendigo or Melbourne Campus through our Hallmark Scholars Program.

NB: Meeting minimum prerequisites does not guarantee an offer of a place. Entry into all La Trobe courses is based on competitive selection and there may be limited places available.

If you intend to apply only to La Trobe you can apply direct to the University until applications close in December. Late direct applications may be accepted.

Please note: VTAC applications cannot be withdrawn in order to submit a direct application. The same selection criteria and entry standards are applied to VTAC and direct applications.

To find out more about this course and studying at La Trobe: - ask us a question - chat online - visit our FAQ page - connect with us on Facebook, Twitter or Instagram - call us on 1300 135 045.

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

In the first year of this degree, you'll explore the basics of animal, plant and microbial biology through the lenses of cell biology, genetics, evolution, biodiversity and ecology. In second and third year, you can specialise through a choice of majors including botany, microbiology, zoology, biochemistry or genetics.

You'll get plenty of hands-on experience in our labs or on field trips to diverse habitats across Victoria. You'll be exposed to cutting edge biological research via world-class research institutes (the La Trobe Institute of Molecular Science and Centre for AgriBiosciences) and you'll have access to the La Trobe Wildlife Sanctuary on our Melbourne Campus.

During your field excursions you'll learn techniques to survey animal and plant biodiversity. During lab classes you'll gain the skills to conduct scientific experiments and develop and present your own work.

Along with practical and theoretical classes, we'll help you prepare for the workplace through opportunities for paid work experience.

TOEFL Paper-based Test - a minimum overall score of 550 with a score of 5 or more in the Test of Written English;

TOEFL Internet-based Test - a minimum overall score of 60 with a minimum for SLR 18; W 22;

Satisfactory completion of the English for Further Studies Advanced Stage 5B (EFS5 UG minimum 60 per cent) which is available from La Trobe Melbourne; for more information please visit the La Trobe Melbourne website.

La Trobe Melbourne Foundation Studies: 60 per cent final result in a course;

English as the language of instruction in tertiary studies may be accepted. Please note: English as the language of instruction in previous study will not be accepted as a basis of admission (English) for courses where the approved test score requirement is above an IELTS 6.5 with no band score lower than 6.0.

Pearson Test of English (Academic) (PTE): a minimum score of 57 with no communicative skill score less than 50.

Cambridge Certificate of Advanced English (CAE): a grade of B or higher.

Cambridge Certificate of Proficiency in English (CPE): a pass grade of C or higher;

or approved international equivalent.

If you do not meet these entry requirements you might be interested in La Trobe's Foundation Studies and Diploma Programs, which provide an alternative pathway to La Trobe's undergraduate program. For more information please visit the La Trobe Melbourne website.

NB: The scores above are indicative only and may change based on the number of applications received and places available. Achieving the above listed scores does not guarantee an offer of a place.

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

First year foundational science subjects focus on biology and chemistry. Second year subjects - biosciences, medical science, biochemistry, genetics, anatomy, physiology and microbiology - will lead you towards your third year specialisation and postgraduate studies.

You'll learn about the human body in health and sickness, and gain knowledge of medical biochemistry, microbiology, pharmacology, cell and molecular biology, anatomy, physiology, infectious diseases and neuroscience.

You'll discover the symptoms of disease, learn how to analyse scientific and medical data, and do practical lab work. Third year advanced biochemistry and medical sciences internships and lab courses give you more hands-on experience. We'll also show you how to read, research and interpret scientific publications and teach you to meaningfully convey scientific and biomedical science information in writing.

Through this degree, you'll have access to the La Trobe Institute for Molecular Science - our $100 million teaching and research facility. With our industry cadetship program, you can also gain workplace experience, building on your skills and industry connections.

First year students may be eligible for the Dean's Scholarship for Academic Excellence or other undergraduate scholarships. We also offer overseas study opportunities, including clinical placements and volunteering.

You can apply to study this course through our Hallmark Scholars Program. See the listing for Hallmark Course Group C for more details.

TOEFL Paper-based Test - a minimum overall score of 550 with a score of 5 or more in the Test of Written English;

TOEFL Internet-based Test - a minimum overall score of 60 with a minimum for SLR 18; W 22;

Satisfactory completion of the English for Further Studies Advanced Stage 5B (EFS5 UG minimum 60 per cent) which is available from La Trobe Melbourne; for more information please visit the La Trobe Melbourne website.

La Trobe Melbourne Foundation Studies: 60 per cent final result in a course;

English as the language of instruction in tertiary studies may be accepted. Please note: English as the language of instruction in previous study will not be accepted as a basis of admission (English) for courses where the approved test score requirement is above an IELTS 6.5 with no band score lower than 6.0.

Pearson Test of English (Academic) (PTE): a minimum score of 57 with no communicative skill score less than 50.

Cambridge Certificate of Advanced English (CAE): a grade of B or higher.

Cambridge Certificate of Proficiency in English (CPE): a pass grade of C or higher;

or approved international equivalent.

If you do not meet these entry requirements you might be interested in La Trobe's Foundation Studies and Diploma Programs, which provide an alternative pathway to La Trobe's undergraduate program. For more information please visit the La Trobe Melbourne website.

NB: The scores above are indicative only and may change based on the number of applications received and places available. Achieving the above listed scores does not guarantee an offer of a place.

Please apply through VTAC if youre completing your VCE or International Baccalaureate (IB) in Victoria, or apply through UAC if youre completing your HSC or IB in New South Wales.

A limited number of La Trobe College Excellence Scholarships are available, offering up to 25% reduction on your postgraduate course fees. Learn More

The delivery of this course can vary between campuses. For detailed information please select the relevant campus:

Our law degree has a strong focus on global and social justice. You'll study the essential legal areas like criminal law, constitutional law and legal ethics. You'll also cover science-related topics such as intellectual property and medicine and the law. Visiting lecturers from high profile law firms will help you develop an understanding of dispute resolution and recent legal developments.

You'll have the opportunity to participate in additional studies including Honours in Laws, subjects from our Global Business Law program at the Master's level, and clinical practice in a law firm.

The science component of this degree can be tailored to your interests. Choose from a range of specialisations including botany, computer science, psychology, chemistry and physics, and get hands-on experience through lab studies and field trips.

Only the first two years of this course are offered in Bendigo. While it is possible to arrange long-distance learning, we recommend transferring to the Melbourne Campus to complete your degree with a wider selection of subjects. Law electives are also available in intensive delivery at Melbourne in summer and winter schools.

TOEFL Paper-based Test: minimum score of 575 (minimum score of 5 in the Test of Written English).

TOEFL Internet-based Test: minimum score of 80 with minimum overall for SLR 18; W 22.

La Trobe Melbourne (ELICOS): completion of English for Further Studies Advanced Stage 5B Certificate at postgraduate (EFS5 (70 per cent) PG1) level. For more information please visit the La Trobe Melbourne website.

La Trobe Melbourne Foundation Studies: 70 per cent final result in a course.

English as the language of instruction in tertiary studies may be accepted. Please note: English as the language of instruction in previous study will not be accepted as a basis of admission (English) for courses where the approved test score requirement is above an IELTS 6.5 with no band score lower than 6.0.

Pearson Test of English (Academic) (PTE): minimum score of 64 with no communicative skill score less than 59.

Cambridge Certificate of Advanced English (CAE): a grade of B or higher.

Cambridge Certificate of Proficiency in English (CPE): a grade of C or higher.

or approved international equivalent.

If you do not meet these entry requirements you might be interested in La Trobe's Foundation Studies and Diploma Programs, which provide an alternative pathway to La Trobe's undergraduate program. For more information please visit the La Trobe Melbourne website. NB: The scores above are indicative only and may change based on the number of applications received and places available. Achieving the above listed scores does not guarantee an offer of a place.

Continue reading here:
Biochemistry and molecular biology - La Trobe University

What is Neuroscience ? – All Psychology Careers

Rapid advances in technology combined with knowledge about how the brain and nervous system work have ushered in progress once considered purely science fiction, but today falling under a growing area of scientific study called neuroscience.

Take, for example, the case of implanting a sensor into a paralyzed individuals brain. The sensor detects thoughts that the individual has about moving an arm. These thoughts are then sent to a plug on the individuals scalp, which sends signals to a computer that translates the signals into motor movements.

Or consider the practice of placing electrodes under a persons scalp, electrodes connected to a battery-operated generator implanted under the skin near the individuals collarbone. The result? An intervention for a brain-related disorder called essential tremor.

Both of these cutting-edge medical interventions wouldnt have been possible without the field of Neuroscience, an area of specialty that wasnt formalized into its own field until 1971. Since then, the amount of investigation and research completed by those working in the field has grown faster than most other scientific areas of thought and empirical study.

And those individuals with devastating brain and spinal cord injuries, brain diseases and disorders, are the main beneficiaries of these once unimaginable scientific advancements.

The Society for Neuroscience (SfN) defines neurosicence as the study of the nervous system, including the brain, spinal cord, and networks of sensory nerve cells called neurons. It is an interdisciplinary field, meaning that it integrates several disciplines, including psychology, biology, chemistry, and physics.

In studying the nervous system, the field adds to a body of knowledge about human thought, emotion, and behavior the main area of expertise for those working in psychology, especially the field of Neuropsychology.

Both neuropsychologists and neuroscientists focus their research on the understanding of brain disorders, injuries, and deficits. For this reason, these scientists must have a solid understanding of how psychological processes relate to the brains structures and systems, or on the interrelated and inseparable connections between cognition and brain physiology.

To help those with brain disorders, neuroscientists first must understand normal brain functioning. Therefore, many neuroscientific investigations into abnormal brain functioning complement the science of normal brain functioning.

Neuroscientists study a wide range of topics related to the brain and nervous system. Most specialize, however, on a particular disability or problem associated with one brain region or area. The implanting of brain sensors is one example of specialized neuroscientific research.

In an August 2010 interview with The New York Times, John Donohue detailed how his research into combining brain signals with computers resulted in BrainGate, the invention responsible for returning some voluntary movements to paralyzed individuals. He has focused on using BrainGate to help those who have had strokes, incurred spinal cord injuries, or suffer with amyotrophic lateral sclerosis (ALS).

Donoghue, a professor of engineering and neuroscience at Brown University, told reporter Claudia Dreifus, in the article Connecting Brains to the Outside World, that when he entered graduate school in 1976, his desire was to learn how the brain works. But, he realized that that question was too broad, and he needed to break it down into a more easily studied sub-topic, which became how does the cerebral cortex allow thoughts to become action?

In the 1980s, he and colleagues from his laboratory worked on technologies that permitted them to distinguish where brain activity occurred when the body moved, such as when arms or legs moved. These technologies led to the invention of the brain sensor.

In 2004, Donoghue and other researchers implanted the sensor into an individual that had a spinal cord injury that left him paralyzed. When they turned on BrainGate the sensor attached to a scalp plug thats attached to a computer they could see activity in his brain light up when he thought about moving his left or right hand. In other words, even though his body couldnt produce the movement, his brain still processed the command.

In the NYT article, Donohue related how up until that point, many assumed that brain function was reduced or nonexistent after a debilitating spinal cord injury. But this new technology pointed out that it was the connection between the brain and the desired movement that was injured, not the brain itself. In other words, theres a break or disconnect between the brain the other parts of the nervous system.

This has profound implications not for only BrainGate, but for anyone thinking about nervous system injuries, Donohue told the NYT.

Ultimately, Donoghue said, at the goal of BrainGate is to return lives impacted by neurological injuries back to a state of normalcy, or as close as possible to the productive lives they had before the injuries or illnesses.

Neuroscientists at the Mayo Clinic also want individuals suffering with brain and neurological disorders to regain normal functioning and their livelihoods. In its quarterly publication, Sharing Mayo Clinic, Mayo describes how its research into deep brain stimulation (DBS) led to some of the first applications of this technology in the United States.

In one particular case, world-renowned violinist Roger Frisch, associate concertmaster of the Minnesota Orchestra, thought his music career would be over after being diagnosed with a condition known as essential tremor.

A progressive neurological disorder, essential tremor results in tremors during certain movements, such as eating or writing. Tremors can also occur in the head, neck, jaw, and voice.

In Frischs case, the tremors occurred in his arms while performing. Kendall Lee, M.D., Ph.D., and specialist in DBS at Mayo Clinic, believed that locating the tremors source, or area of Frischs brain where the tremors materialized, could help alleviate them.

In order to accomplish this localization, Mayos surgical team had Frisch perform in the surgical suite where a device engineered by Mayos researchers measured the exact movement of Frischs hand, tracing and mapping the movement to the area of the activated brain.

The newsletter called the device an accelerometer, a small semiconductor device that measures movement in three dimensions. It was attached to a violin bow and connected to an amplifier and radio system.

The device transmitted data to a computer monitor where the research team saw the genesis and progress of the tremor as the bow moved across the strings. Electrodes were placed on Frischs skull where the researchers located the misfiring brain signals, and the tremors stopped.

Frisch then went into surgery so that the wires could be placed under the scalp and connected to a battery-operated pulse generator that sends constant electrical pulses to the brain. The generator is implanted under the skin by the collarbone.

If you are interested in the fields of Neuropsychology and Neuroscience, in research and medical facilities designed to treat individuals suffering from brain injuries and dysfunctions, contact schools offering degrees in psychology. One career path for neuroscience professionals is to major in neuropsychology and take additional coursework in biology, physiology, anatomy, chemistry, and other sciences. A Ph.D. is required to work in most areas of neuroscience.

Diagnosing traumatic brain injury (TBI) remains a tedious and often difficult process for many healthcare professionals, especially in cases of mild or moderate TBI. As a result, some individuals dont receive treatment or intervention for possible neurological deficits.

Banyan Biomarkers, a Florida-based privately held company wants to solve that problem.

Founded by two neuroscientists, Banyans researchers are trying to identify biomarkers in blood tests that accurately predict head injury. Research by Banyans scientists and published in the journal Critical Care Medicine, stated that a 66-patient study of individuals with severe brain injury had elevated levels of UCH-LI 16 times the level of those without a head injury.

Banyans scientists also stated in another article for the European Journal of Neuroscience that laboratory studies with rats showed blood tests with increased levels of UCH-LI for those with brain injury and stroke.

Battlefield explosions and sports injuries often leave individuals dazed but seemingly fine, performing some neurological tests adequately, but actually needing medical treatment, rest and recovery.

According to the International Brain Injury Association, the Glasgow Coma Scale (GCS) is currently used to divide individuals into mild, moderate, and severe injury. This is a symptom-based neurological test, checking vital signs, heart rate, blood pressure, and the patients thinking in terms of memory and consciousness.

A blood test showing a definitive marker for brain injury would significantly increase an accurate diagnosis for those with mild and moderate head injuries.

Of the mild TBI patients 40-50% suffer persistent neurological problems from one to three months following injury, and 25% after one year, according to the International Brain Injury Association website.

Even severe cases of brain injury can be hard to recognize. In 2009, actress Natasha Richardson died from a skiing accident that injured her head. Assuring her family that she was fine, she did not receive medical treatment as quickly as her injury required.

Read more:
What is Neuroscience ? - All Psychology Careers

Department of Neuroscience | Ohio State Neurological Departments

The Department of Neuroscience is part of Ohio State's multidisciplinary Neurological Institute. The department is closely aligned with the Neuroscience Graduate Program, which includes faculty from Neuroscience who work to advance our understanding of the brain and behavior. Our focus is on cross-disciplinary education and scientific study of nervous systems, including neurological and psychiatric conditions.

Were a top-ranked center for fundamental, translational and clinical research conducted by faculty, fellows and students. Unique research opportunities include a Neuroscience Center Core Program made possible by a grant from the National Institute for Neurological Disorders and Stroke. This supports core facilities and services in areas such as mouse and zebrafish genetics, nerve injury, rodent behavior, neurophysiology, muscle physiology, xenografting and small animal imaging.

Department resources include access to more than 25 state-of-the-art medical center research facilities and services. These involve proteomics, microarray, nucleic acid, comparative pathology and mouse phenotyping, analytical cytometry and biostatistics.

Support for clinical and translational research is provided by the Center for Clinical and Translational Science, funded by a National Institutes of Health (NIH) Clinical Translational Science Award.

Link:
Department of Neuroscience | Ohio State Neurological Departments

Ph.D. in Neuroscience – University of Nevada, Reno

An interdisciplinary program with 50 faculty members from 10 University departments, the neuroscience Ph.D. gives students a strong foundation across key areas of brain science, as well as advanced training in specialized subdisciplines.

Admissions cycles: Fall, Spring Application deadlines: Dec. 15, Sept. 15 Assistantship types available: Contact department Graduate directors: Michael Webster, Grant Mastick, Jim Kenyon

This program aims to develop the next generation of leading neuroscience academics and researchers. Students receive advanced, specialized training to develop their critical thinking and research skills in preparation for a wide range of possible career avenues, either in academia or the public or private sectors.

The program trains students to possess three key abilities:

Students tailor their curriculum to meet their research interests and professional goals. They may select from a diverse variety of courses within the program, including offerings in biology, computer science, electrical and biomedical engineering, microbiology and immunology, pharmacology, philosophy, psychiatry, psychology, physiology and more.

During the first two years of the program, students complete a track of foundation courses and research experience. They then specialize within a chosen subdiscipline for their research and training in subsequent years, culminating in their dissertation.

Program requirements include coursework in:

Possible elective course subjects include:

Neuroscience faculty members at the University of Nevada, Reno encourage the academic and professional development of students as independent researchers. Working closely with advisers and program directors, students develop a specialized, independent program of study in neuroscience research methodologies.

All applicants to the Integrative Neuroscience Graduate Program -- home to neuroscience Ph.D. -- must meet the admissions standards of the Graduate School. Additionally, they must also submit with their graduate application the following materials:

The program accepts applications each fall. The deadline for completed applications is Feb. 1.

Please contact the department.

You can apply now if you are ready to begin at the University. If you would like to learn more about the program, please contact:

Michael Webster, Ph.D. Professor of Psychology, Co-Director Neuroscience Graduate Program (775) 682-8691 mwebster@unr.edu

Grant Mastick, Ph.D. Professor, Co-Director Neuroscience Graduate Program, Co-Director Cell Biology Center for Biomedical Research Excellence (775) 784-6168 gmastick@unr.edu

Jim Kenyon, Ph.D. Professor, Co-Director Neuroscience Graduate Program (775) 682-8832 jlkenyon@medicine.nevada.edu

More here:
Ph.D. in Neuroscience - University of Nevada, Reno

Immunology Journals | Peer Reviewed | High Impact Articles list

Index Copernicus Value: 67.47

Immunology is a branch of biomedical science which deals with an organisms response towards an invading environmental factor. This process involves a complex interplay of invading particle and defence system of the host organism along with successive cascading molecular mechanism to eliminate the invading agent.

This peer reviewed journal includesclinical and cellular Immunologicalaspects such asSystemic Lupus Erythmatosus,Cancer Immunology, Tumor Biology,Macrophage Polarization,Transplantation Immunology, Innate Immunology, Adaptive Immunity, Cellular & Molecular Immunology, Vaccine Development,Signal Transduction, Innate Immunity, Cancer Immunotherapy,Inflammatory Disorders, Medical Immunology,Diagnostic Immunology, Clinical Immunology, HIV Immunology,Allergy & Immunology,Immunomodulation,Multiple Sclerosis, Neuroinflammatory Diseases, Clinical & Vaccine Immunology, Clinical Experimental Immunology, T-cell Immunologyetc.

This Science Journal publishes research articles, reviews, case studies, commentaries, short communications, and letters to the editor on various aspects of Cellular and Clinical Immunology making them freely available worldwide.To attain high impact factor, quality articles are expected from all over the world for this open access and peer reviewed front running journal.

Journal of Clinical & Cellular Immunology is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems used by most of the best open access journals. Review processing is performed by the editorial board members of Journal of Clinical & Cellular Immunology or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript. Annual reviews of Immunology Journal is also shared with authors.

Authors are requested to submit manuscripts at http://www.editorialmanager.com/clinicalgroup/ or send as an e-mail attachment to the Editorial Office at clinimmunology@immunologyjournals.com; cjm.eic.jcci@omicsonline.org

OMICS International organizes 1000+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Clinical immunology is the branch of Immunology that deals with studies of diseases caused due to immune system disorders. Clinical Immunology falls into two categories Immunodeficiency and Autoimmunity. Immunodeficiency is a category in which adequate response is not provided by the immune system. Whereas in Autoimmunity the immune system attacks its own host body. Related Journals of Clinical Immunology

Immunology Journals: Journal of Vaccines & Vaccination, Rheumatology: Current Research, Immunome Research, Journal of Allergy & Therapy, Journal of AIDS & Clinical Research, Allergy: European Journal of Allergy and Clinical Immunology, Autoimmunity Journal, Clinical and Experimental Immunology, Autoimmunity Reviews, Clinical Immunology, Current Opinion in Allergy and Clinical Immunology, Current Opinion in Immunology, Journal of Asthma.

Cellular immunology deals with activities of cells in experimental or clinical situations. It is the interactions among cells and molecules of the immune system that contribute to the recognition and elimination of pathogens.

Related Journals of Cellular Immunology

Open Access Immunology Journals: Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Cellular Immunology, Central-European Journal of Immunology, Chinese Journal of Microbiology and Immunology, Clinical and Developmental Immunology, Clinical and Experimental Immunology, Clinical and Vaccine Immunology.

Translational immunology is the process the use immunological discoveries to develop practical solutions for human problems. Examples include the development of vaccines or the engineering of new types of drugs to treat disorders.

Related Journals of Translational Immunology Immunology Journals List: Journal of Allergy & Therapy, Journal of AIDS & Clinical Research, Immunome Research, Journal of Allergy & Therapy, International Immunology, Current Topics in Microbiology and Immunology, Advances in Immunology, Cellular Immunology, Critical Reviews in Immunology.

Transplantation Immunology deals with monitoring Immune responses provided by the body for transplantation to prevent rejection of transplanted tissue or organ.

Related Journals of Transplantation Immunology

Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Clinical Transplantation, Xenotransplantation, Annals of Transplantation, Cellular Therapy and Transplantation, Progress in Transplantation.

Neuroinflammatory disorder is the study of conditions where immune responses which damage components of the nervous system. It includes many neurodegenerative disorders like Alzheimers disease, Parkinsons disease and Multiple Sclerosis. It is also associated with aging and Traumatic brain injury.

Related Journals of Neuroinflammatory Disorders

Journal of Vaccines & Vaccination, Rheumatology: Current Research, Immunome Research, Journal of Allergy & Therapy, Journal of Neuroinflammation, Multiple Sclerosis, Multiple Sclerosis and Related Disorders, Alzheimer's Research and Therapy, Parkinsonism and Related Disorders.

Tumour immunology is the study of interactions between the immune system and tumour cells. It aims to discover innovative cancer immunotherapies to treat and retard progression of the disease.

Related Journals of Tumor Immunology

Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Tumor Biology, Brain Tumor Pathology, Immunology Reviews, Tumor Targeting, Journal of Tumor Marker Oncology, Nature Immunology, Tumor Diagnostik und Therapie, Cancer Case Presentations: The Tumor Board.

Vaccine Immunology deals with preparation of vaccine based on immune response of the body. Vaccine can be antigenic substance prepared from the causative agent of a disease or a synthetic substitute to provide immunity against that disease.

Related Journals of Vaccine Immunology

Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Clinical and Vaccine Immunology, Paediatric Food Allrgy, Human Vaccines and Immunotherapeutics, Paediatric Immunology, Journal of Immune Based Therapies and Vaccines, Paediatric Allergy & Immunology, Vaccine & immunization news : the newsletter of the Global Programme for Vaccines and Immunization.

Adaptive immunity is an important part of the immune system. It is protection from an infectious disease agent that is mediated by B- and T- lymphocytes following exposure to specific antigen, and characterized by immunological memory.

Related Journals of Adaptive Immunity

Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Genes and Immunity, Brain, Behavior, and Immunity, Immunity and Ageing, Autoimmunity Highlights, Open Autoimmunity Journal.

Inflammatory abnormalities results in the body own immune system attacking the cells or tissues and may cause inflammation, which results in chronic pain, redness, swelling, stiffness, and damage to normal tissues.

Related Journals of Inflammatory Disorders

Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Immunology, Journal of Allergy & Therapy, Inflammation and Allergy - Drug Targets, Journal of Inflammation Research, Journal of Ophthalmic Inflammation and Infection, European Journal of Inflammation, Journal of Inflammation.

Ocular Immunology is the understanding of the immune response towards various allergies, inflammation and infections of ocular tissue including retina and uveitis.

Related Journals of Ocular Immunology and inflammation

Journal of Vaccines & Vaccination, Rheumatology: Current Research, Immunome Research, Journal of Allergy & Therapy, Ocular Immunology and Inflammation, Cutaneous and Ocular Toxicology, Journal of Ocular Biology, Diseases, and Informatics, Clinica Oculistica e Patologia Oculare.

It is the scientific study of infections caused by different microorganism which can lead to discovery of potent anti-microbial drug and other antibiotics.

Related Journals of Microbial Immunology

Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Applied and Environmental Microbiology, Asthma Journal, Microbiology and Molecular Biology Reviews, Trends in Microbiology, Current Opinion in Microbiology, Current Topics in Microbiology and Immunology, European Journal of Clinical Microbiology and Infectious Diseases.

Immunodiagnostics is a diagnostic method that relies on antigen-antibody reaction for detection of the disease. Immunologic methods are used as tools in the treatment and prevention of infectious diseases and immune-mediated diseases. They have high specificity and sensitivity which all depends on the value of antibody detection.

Related Journals of Diagnostic Immunology

Journal of Allergy & Therapy, Journal of AIDS & Clinical Research, Immunome Research, Journal of Allergy & Therapy, Clinical and Vaccine Immunology : CVI, Pediatric Allergy and Immunology, Supplement, Journal of Immunology Research, Comparative Immunology, Microbiology and Infectious Diseases, Clinical and Applied Immunology Reviews.

viral immunology is the study of viral infections and immune responses towards viral infections which can cause deleterious effect on the functions of the cells. It includes both DNA and RNA viral infections.

Related Journals of Viral Immunology

Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Viral Immunology, International Immunology, Current Topics in Microbiology and Immunology, Scandinavian Journal of Immunology, Medical Microbiology and Immunology.

Immunotherapy is a form of preventive and anti-inflammatory treatment of allergy. It also deals with the study of identification of allergen and inflammatory mediators involved in allergic reaction and its treatment.

Related Journals of Allergy Immunology

Immunome Research, Journal of Allergy & Therapy, Journal of Vaccines & Vaccination, Rheumatology: Current Research, Annals of Allergy, Asthma and Immunology, International Archives of Allergy and Immunology, Pediatric Allergy and Immunology, Current Opinion in Allergy and Clinical Immunology.

Evolutionary immunology is the study of the evolution of immunity and the immune system over ages. It includes the study and historical development of the ability to recognize foreign antigenic material.

Related Journals of Evolutionary Immunology

Journal of AIDS & Clinical Research, Immunome Research, Rheumatology: Current Research, Journal of Allergy & Therapy, Trends in Immunology, Transplant Immunology, European Journal of Immunology, Clinical and Experimental Immunology, Advances in Immunology.

Journal of Clinical & Cellular Immunology is supporting 4th International Conference and Exhibition on Clinical & Cellular Immunology which is going to be held during September 28-30, 2015, at Houston, USA. The theme of the conference is From Basic Immune Understanding to Clinical Breakthroughs.

Excerpt from:
Immunology Journals | Peer Reviewed | High Impact Articles list

Stanford Biochemistry

The Department of Biochemistry was founded in 1959 when Arthur Kornberg was recruited as a fundamental part of the move of the Stanford Medical School from San Francisco to the main Stanford campus. Innovations established at that time included the mixing of students and postdoctoral fellows in common laboratories so that the different research groups would be familiar with each other's research work and cross-fertilization would be inevitable. Specialized reagents were shared and major instruments were made available to everyone. Benches were not owned by a particular faculty member, but fair and equitable sharing of space was enjoyed in an unprecedented way of carrying out research in a department setting. We have embraced and maintained these approaches over time, and everyone in the department continues to prosper under this unusual innovative mode of operation, rarely found anywhere else in the world.

In the first decade of the department, there was a nearly complete focus on DNA and RNA biochemistry, and methodologies were also focused on hard-core biochemical approaches of enzyme purification and characterization. The current department is now enormously diverse with nearly everyone using interdisciplinary approaches of biochemistry, genetics, biophysics, structural biology, high-resolution light microscopy, and other innovative methodologies, often developed by Biochemistry students and postdoctoral fellows during the course of their work. Thus, genetic engineering, high-throughput RNA expression analysis, and single molecule analysis all came out of the Biochemistry Department and are fueling current advances in biosciences, biotechnology and medicine.

See the article here:
Stanford Biochemistry

Immunology – St. Jude Childrens Research Hospital

Departmental Focus

Immunology is the study of the immune system, the body's defense against infectious disease. In this complex system a defect in a single gene or the control of a single cell can have an enormous effect on the health of the individual. In this way, the immune system and cancer are similar. The Department of Immunology at St. Jude studies the biology of the system whose cells are a major source of childhood cancers, and by understanding these cells and how they are controlled, we gain new insights into such cancers.

Department of Immunology MS 351, Room E7050 St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis, TN 38105-3678

Email: douglas.green@stjude.org Phone: (901) 595-3488 Fax: (901) 595-5766

Preferred contact method: email

See the article here:
Immunology - St. Jude Childrens Research Hospital

Neuroscience of free will – Wikipedia

Neuroscience of free will, a part of neurophilosophy, is the study of the interconnections between free will and neuroscience.

As it has become possible to study the human living brain, researchers have begun to watch decision making processes at work. Findings could carry implications for our sense of agency, moral responsibility, and our understanding of consciousness in general.[1][2][3] One of the pioneering studies in this domain was designed by Benjamin Libet,[4] while other studies have attempted to predict participant actions before they make them.[5]

The field remains highly controversial. There is no consensus among researchers about the significance of findings, their meaning, or what conclusions may be drawn. The precise role of consciousness in decision making therefore remains unclear.

Thinkers like Daniel Dennett or Alfred Mele consider the language used by researchers. They explain that "free will" means many different things to different people (e.g. some notions of free will are dualistic, some not). Dennett insists that many important and common conceptions of "free will" are compatible with the emerging evidence from neuroscience.[6][7][8][9]

...the current work is in broad agreement with a general trend in neuroscience of volition: although we may experience that our conscious decisions and thoughts cause our actions, these experiences are in fact based on readouts of brain activity in a network of brain areas that control voluntary action...It is clearly wrong to think of [feeling of willing something] as a prior intention, located at the very earliest moment of decision in an extended action chain. Rather, W seems to mark an intention-in-action, quite closely linked to action execution.

One significant finding of modern studies is that a person's brain seems to commit to certain decisions before the person becomes aware of having made them. Researchers have found delays of about half a second (discussed in sections below). With contemporary brain scanning technology, other scientists in 2008 were able to predict with 60% accuracy whether subjects would press a button with their left or right hand up to 10 seconds before the subject became aware of having made that choice.[5] These and other findings have led some scientists, like Patrick Haggard, to reject some forms of "free will". To be clear, no single study would disprove all forms of free will. This is because the term "free will" can encapsulate different hypotheses, each of which must be considered in light of existing empirical evidence.

An ancient model of the mind known as the five-aggregate model[13] is useful to shed light on the neuroscience of free will. This model describes that all our experiences involve the moment-by-moment manifestation of material form, feelings, perception, volition, and sensory consciousness. Using this model, the manifestation of experience of both the research subject who participates in such an experiment as well as the experience of the researcher can be analyzed separately. In the participant, when he or she is given instructions to engage in the experimental task (sensory consciousness through auditory or visual sensory stimuli), after the participant understands the instructions (perception), the intention to initiate the activity (volition) happens. In terms of the researchers mind-stream that also manifests from moment-to-moment, first there is planning the experiment followed by conducting the experiment (aggregate of volition). Then, observing the brain cortex activity of the participant happens (visual sensory stimuli), followed by conclusions (aggregate of perception) relating to the activity of the participants brain.[13] Scientific investigations represent third-person level of analyses and the subjective experience represents the first-person level of analyses involving the mind (continuously changing sense impressions and mental phenomena) that manifests from moment-to-moment.

There have also been a number of problems regarding studies of free will.[14] Particularly in earlier studies, research relied too much on the introspection of the participants, but introspective estimates of event timing were found to be inaccurate. Many brain activity measures have been insufficient and primitive as there is no good independent brain-function measure of the conscious generation of intentions, choices, or decisions. The conclusions drawn from measurements that have been made are debatable too, as they don't necessarily tell, for example, what a sudden dip in the readings is representing. In other words, the dip might have nothing to do with unconscious decision, since many other mental processes are going on while performing the task.[14] Some of the research mentioned here has gotten more advanced, however, even recording individual neurons in conscious volunteers.[12] Researcher Itzhak Fried says that available studies do at least suggest consciousness comes in a later stage of decision making than previously expected - challenging any versions of "free will" where intention occurs at the beginning of the human decision process.[8]

It is quite likely that a large range of cognitive operations are necessary to freely press a button. Research at least suggests that our conscious self does not initiate all behavior. Instead, the conscious self is somehow alerted to a given behavior that the rest of the brain and body are already planning and performing. These findings do not forbid conscious experience from playing some moderating role, although it is also possible that some form of unconscious process is what is causing modification in our behavioral response. Unconscious processes may play a larger role in behavior than previously thought.

It may be possible, then, that our intuitions about the role of our conscious "intentions" have led us astray; it may be the case that we have confused correlation with causation by believing that conscious awareness necessarily causes the body's movement. This possibility is bolstered by findings in neurostimulation, brain damage, but also research into introspection illusions. Such illusions show that humans do not have full access to various internal processes. The discovery that humans possess a determined will would have implications for moral responsibility. Neuroscientist and author Sam Harris believes that we are mistaken in believing the intuitive idea that intention initiates actions. In fact, Harris is even critical of the idea that free will is "intuitive": he says careful introspection can cast doubt on free will. Harris argues "Thoughts simply arise in the brain. What else could they do? The truth about us is even stranger than we may suppose: The illusion of free will is itself an illusion".[15] Philosopher Walter Jackson Freeman III nevertheless talks about the power of even unconscious systems and actions to change the world according to our intentions. He writes "our intentional actions continually flow into the world, changing the world and the relations of our bodies to it. This dynamic system is the self in each of us, it is the agency in charge, not our awareness, which is constantly trying to keep up with what we do."[16] To Freeman, the power of intention and action can be independent of awareness.

Some thinkers like neuroscientist and philosopher Adina Roskies think these studies can still only show, unsurprisingly, that physical factors in the brain are involved before decision making. In contrast, Haggard believes that "We feel we choose, but we don't".[8] Researcher John-Dylan Haynes adds "How can I call a will 'mine' if I don't even know when it occurred and what it has decided to do?".[8] Philosophers Walter Glannon and Alfred Mele think some scientists are getting the science right, but misrepresenting modern philosophers. This is mainly because "free will" can mean many things: It is unclear what someone means when they say "free will does not exist". Mele and Glannon say that the available research is more evidence against any dualistic notions of free will - but that is an "easy target for neuroscientists to knock down".[8] Mele says that most discussions of free will are now had in materialistic terms. In these cases, "free will" means something more like "not coerced" or that "the person could have done otherwise at the last moment". The existence of these types of free will is debatable. Mele agrees, however, that science will continue to reveal critical details about what goes on in the brain during decision making.[8]

"[Some senses of free will] are compatible with what we are learning from science...If only that was what scientists were telling people. But scientists, especially in the last few years, have been on a rampage - writing ill-considered public pronouncements about free will which... verge on social irresponsibility.

This issue may be controversial for good reason: There is evidence to suggest that people normally associate a belief in free will with their ability to affect their lives.[2][3] Philosopher Daniel Dennett, author of Elbow Room and a supporter of deterministic free will, believes scientists risk making a serious mistake. He says that there are types of free will that are incompatible with modern science, but he says those kinds of free will are not worth wanting. Other types of "free will" are pivotal to people's sense of responsibility and purpose (see also "believing in free will"), and many of these types are actually compatible with modern science.[17]

The other studies described below have only just begun to shed light on the role that consciousness plays in actions and it is too early to draw very strong conclusions about certain kinds of "free will". It is worth noting that such experiments so far have dealt only with free will decisions made in short time frames (seconds) and may not have direct bearing on free will decisions made ("thoughtfully") by the subject over the course of many seconds, minutes, hours or longer. Scientists have also only so far studied extremely simple behaviors (e.g. moving a finger).[18] Adina Roskies points out five areas of neuroscientific research: 1.) action initiation, 2.) intention, 3). decision, 4.) Inhibition and control, and 5.) the phenomenology of agency, and for each of these areas Roskies concludes that the science may be developing our understanding of volition or "will," but it yet offers nothing for developing the "free" part of the "free will" discussion.[19][20][21][22]

There is also the question of the influence of such interpretations in people's behaviour.[23][24][25] In 2008, psychologists Kathleen Vohs and Jonathan Schooler published a study on how people behave when they are prompted to think that determinism is true. They asked their subjects to read one of two passages: one suggesting that behaviour boils down to environmental or genetic factors not under personal control; the other neutral about what influences behaviour. The participants then did a few math problems on a computer. But just before the test started, they were informed that because of a glitch in the computer it occasionally displayed the answer by accident; if this happened, they were to click it away without looking. Those who had read the deterministic message were more likely to cheat on the test. "Perhaps, denying free will simply provides the ultimate excuse to behave as one likes," Vohs and Schooler suggested.[26][27]

A pioneering experiment in this field was conducted by Benjamin Libet in the 1980s, in which he asked each subject to choose a random moment to flick their wrist while he measured the associated activity in their brain (in particular, the build-up of electrical signal called the Bereitschaftspotential (BP), which was discovered by Kornhuber & Deecke in 1965[28]). Although it was well known that the Bereitschaftspotential (sometimes also termed "readiness potential") preceded the physical action, Libet asked how the Bereitschaftspotential corresponded to the felt intention to move. To determine when the subjects felt the intention to move, he asked them to watch the second hand of a clock and report its position when they felt that they had felt the conscious will to move.[29]

Libet found that the unconscious brain activity leading up to the conscious decision by the subject to flick his wrist began approximately half a second before the subject consciously felt that he had decided to move.[29][30] Libet's findings suggest that decisions made by a subject are first being made on a subconscious level and only afterward being translated into a "conscious decision", and that the subject's belief that it occurred at the behest of his will was only due to his retrospective perspective on the event.

The interpretation of these findings has been criticized by Daniel Dennett, who argues that people will have to shift their attention from their intention to the clock, and that this introduces temporal mismatches between the felt experience of will and the perceived position of the clock hand.[31][32] Consistent with this argument, subsequent studies have shown that the exact numerical value varies depending on attention.[33][34] Despite the differences in the exact numerical value, however, the main finding has held.[5][35][36] Philosopher Alfred Mele criticizes this design for other reasons. Having attempted the experiment himself, Mele explains that "the awareness of the intention to move" is an ambiguous feeling at best. For this reason he remained skeptical of interpreting the subjects' reported times for comparison with their 'Bereitschaftspotential'.[37]

In a variation of this task, Haggard and Eimer asked subjects to decide not only when to move their hands, but also to decide which hand to move. In this case, the felt intention correlated much more closely with the "lateralized readiness potential" (LRP), an ERP component which measures the difference between left and right hemisphere brain activity. Haggard and Eimer argue that the feeling of conscious will must therefore follow the decision of which hand to move, since the LRP reflects the decision to lift a particular hand.[33]

A more direct test of the relationship between the Bereitschaftspotential and the "awareness of the intention to move" was conducted by Banks and Isham (2009). In their study, participants performed a variant of the Libet's paradigm in which a delayed tone followed the button press. Subsequently, research participants reported the time of their intention to act (e.g., Libet's "W"). If W were time-locked to the Bereitschaftspotential, W would remain uninfluenced by any post-action information. However, findings from this study show that W in fact shifts systematically with the time of the tone presentation, implicating that W is, at least in part, retrospectively reconstructed rather than pre-determined by the Bereitschaftspotential.[38]

A study conducted by Jeff Miller and Judy Trevena (2009) suggests that the Bereitschaftspotential (BP) signal in Libet's experiments doesn't represent a decision to move, but that it's merely a sign that the brain is paying attention.[39] In this experiment the classical Libet experiment was modified by playing an audio tone indicating to volunteers to decide whether to tap a key or not. The researchers found that there was the same RP signal in both cases, regardless of whether or not volunteers actually elected to tap, which suggests that the RP signal doesn't indicate that a decision has been made.[40][41]

In a second experiment, researchers asked volunteers to decide on the spot whether to use left hand or right to tap the key while monitoring their brain signals, and they found no correlation among the signals and the chosen hand. This criticism has itself been criticized by free-will researcher Patrick Haggard, who mentions literature that distinguishes two different circuits in the brain that lead to action: a "stimulus-response" circuit and a "voluntary" circuit. According to Haggard, researchers applying external stimuli may not be testing the proposed voluntary circuit, nor Libet's hypothesis about internally triggered actions.[42]

Libet's interpretation of the ramping up of brain activity prior to the report of conscious "will" continues to draw heavy criticism. Studies have questioned participants' ability to report the timing of their "will". Authors have found that preSMA activity is modulated by attention (attention precedes the movement signal by 100ms), and the prior activity reported could therefore have been product of paying attention to the movement.[43] They also found that the perceived onset of intention depends on neural activity that takes place after the execution of action. Transcranial magnetic stimulation (TMS) applied over the preSMA after a participant performed an action shifted the perceived onset of the motor intention backward in time, and the perceived time of action execution forward in time.[44]

Others have speculated that the preceding neural activity reported by Libet may be an artefact of averaging the time of "will", wherein neural activity does not always precede reported "will".[34] In a similar replication they also reported no difference in electrophysiological signs before a decision not to move, and before a decision to move.[39]

Despite his findings, Libet himself did not interpret his experiment as evidence of the inefficacy of conscious free will he points out that although the tendency to press a button may be building up for 500 milliseconds, the conscious will retains a right to veto any action at the last moment.[45] According to this model, unconscious impulses to perform a volitional act are open to suppression by the conscious efforts of the subject (sometimes referred to as "free won't"). A comparison is made with a golfer, who may swing a club several times before striking the ball. The action simply gets a rubber stamp of approval at the last millisecond. Max Velmans argues however that "free won't" may turn out to need as much neural preparation as "free will" (see below).[46]

Some studies have however replicated Libet's findings, whilst addressing some of the original criticisms.[47] A recent study has found that individual neurons were found to fire 2 seconds before a reported "will" to act (long before EEG activity predicted such a response).[12] Itzhak Fried replicated Libet's findings in 2011 at the scale of the single neuron. This was accomplished with the help of volunteer epilepsy patients, who needed electrodes implanted deep in their brain for evaluation and treatment anyway. Now able to monitor awake and moving patients, the researchers replicated the timing anomalies that were discovered by Libet and are discussed in the following study.[12] Similarly to these tests, Chun Siong Soon, Anna Hanxi He, Stefan Bode and John-Dylan Haynes have conducted a study in 2013 claiming to be able to predict the choice to sum or subtract before the subject reports it.[48]

William R. Klemm pointed out the inconclusiveness of these tests due to design limitations and data interpretations and proposed less ambiguous experiments,[14] while affirming a stand on the existence of free will.[49] like Roy F. Baumeister[50] or Catholic neuroscientists such as Tadeusz Pacholczyk. Adrian G. Guggisberg and Annas Mottaz have also challenged Itzhak Fried's findings.[51]

A study by Aaron Schurger and colleagues published in PNAS[52] challenged assumptions about the causal nature of the Bereitschaftspotential itself (and the "pre-movement buildup" of neural activity in general), casting doubt on conclusions drawn from studies such as Libet's[29] and Fried's.[12] See The Information Philosopher[53] and New Scientist[54] for commentary on this study.

A study by Masao Matsuhashi and Mark Hallett, published in 2008, claims to have replicated Libet's findings without relying on subjective report or clock memorization on the part of participants.[47] The authors believe that their method can identify the time (T) at which a subject becomes aware of his own movement. Matsuhashi and Hallet argue that this time not only varies, but often occurs after early phases of movement genesis have already begun (as measured by the readiness potential). They conclude that a person's awareness cannot be the cause of movement, and may instead only notice the movement.

Matsuhashi and Hallett's study can be summarized thus. The researchers hypothesized that, if our conscious intentions are what causes movement genesis (i.e. the start of an action), then naturally, our conscious intentions should always occur before any movement has begun. Otherwise, if we ever become aware of a movement only after it has already been started, our awareness could not have been the cause of that particular movement. Simply put, conscious intention must precede action if it is its cause.

To test this hypothesis, Matsuhashi and Hallet had volunteers perform brisk finger movements at random intervals, while not counting or planning when to make such (future) movements, but rather immediately making a movement as soon as they thought about it. An externally controlled "stop-signal" sound was played at pseudo random intervals, and the volunteers had to cancel their intent to move if they heard a signal while being aware of their own immediate intention to move. Whenever there was an action (finger movement), the authors documented (and graphed) any tones that occurred before that action. The graph of tones before actions therefore only shows tones (a) before the subject is even aware of his "movement genesis" (or else they would have stopped or "vetoed" the movement), and (b) after it is too late to veto the action. This second set of graphed tones is of little importance here.

In this work, "movement genesis" is defined as the brain process of making movement, of which physiological observations have been made (via electrodes) indicating that it may occur before conscious awareness of intent to move (see Benjamin Libet).

By looking to see when tones started preventing actions, the researchers supposedly know the length of time (in seconds) that exists between when a subject holds a conscious intention to move and performs the action of movement. This moment of awareness (as seen in the graph below) is dubbed "T" (the mean time of conscious intention to move). It can be found by looking at the border between tones and no tones. This enables the researchers to estimate the timing of the conscious intention to move without relying on the subject's knowledge or demanding them to focus on a clock. The last step of the experiment is to compare time T for each subject with their Event-related potential (ERP) measures (e.g. seen in this page's lead image), which reveal when their finger movement genesis first begins.

The researchers found that the time of the conscious intention to move T normally occurred too late to be the cause of movement genesis. See the example of a subject's graph below on the right. Although it is not shown on the graph, the subject's readiness potentials (ERP) tells us that his actions start at 2.8 seconds, and yet this is substantially earlier than his conscious intention to move, time "T" (1.8 seconds). Matsuhashi and Hallet concluded that the feeling of the conscious intention to move does not cause movement genesis; both the feeling of intention and the movement itself are the result of unconscious processing.[47]

This study is similar to Libet's in some ways: volunteers were again asked to perform finger extensions in short, self-paced intervals. In this version of the experiment, researchers introduced randomly timed "stop tones" during the self paced movements. If participants were not conscious of any intention to move, they simply ignored the tone. On the other hand, if they were aware of their intention to move at the time of the tone, they had to try to veto the action, then relax for a bit before continuing self-paced movements. This experimental design allowed Matsuhashi and Hallet to see when, once the subject moved his finger, any tones occurred. The goal was to identify their own equivalent of Libet's W, their own estimation of the timing of the conscious intention to move, which they would call "T".

Testing the hypothesis that 'conscious intention occurs after movement genesis has already begun' required the researchers to analyse the distribution of responses to tones before actions. The idea is that, after time T, tones will lead to vetoing and thus a reduced representation in the data. There would also be a point of no return P where a tone was too close to the movement onset for the movement to be vetoed. In other words, the researchers were expecting to see the following on the graph: many unsuppressed responses to tones while the subjects are not yet aware of their movement genesis, followed by a drop in the number of unsuppressed responses to tones during a certain period of time during which the subjects are conscious of their intentions and are stopping any movements, and finally a brief increase again in unsuppressed responses to tones when the subjects do not have the time to process the tone and prevent an action - they have passed the action's "point of no return". That is exactly what the researchers found (see the graph on the right, below).

The graph shows the times at which unsuppressed responses to tones occurred when the volunteer moved. He showed many unsuppressed responses to tones (dubbed "tone events" on the graph) on average up until 1.8 seconds before movement onset, but a significant decrease in tone events immediately after that time. Presumably this is because the subject usually became aware of his intention to move at about 1.8 seconds, which is then labelled point T. Since most actions are vetoed if a tone occurs after point T, there are very few tone events represented during that range. Finally, there is a sudden increase in the number of tone events at 0.1 seconds, meaning this subject has passed point P. Matsuhashi and Hallet were thus able to establish an average time T (1.8 seconds) without subjective report. This, they compared to ERP measurements of movement, which had detected movement beginning at about 2.8 seconds on average for this participant. Since T like Libet's original W was often found after movement genesis had already begun, the authors concluded that the generation of awareness occurred afterwards or in parallel to action, but most importantly, that it was probably not the cause of the movement.[47]

Haggard describes other studies at the neuronal levels as providing "a reassuring confirmation of previous studies that recorded neural populations"[11] such as the one just described. Note that these results were gathered using finger movements, and may not necessarily generalize to other actions such as thinking, or even other motor actions in different situations. Indeed, the human act of planning has implications for free will and so this ability must also be explained by any theories of unconscious decision making. Philosopher Alfred Mele also doubts the conclusions of these studies. He explains that simply because a movement may have been initiated before our "conscious self" has become aware of it does not mean our consciousness does not still get to approve, modify, and perhaps cancel (called vetoing) the action.[55]

The possibility that human "free won't" is also the prerogative of the subconscious is being explored.

Recent research by Simone Khn and Marcel Brass suggests that our consciousness may not be what causes some actions to be vetoed at the last moment. First of all, their experiment relies on the simple idea that we ought to know when we consciously cancel an action (i.e. we should have access to that information ). Secondly, they suggest that access to this information means humans should find it easy to tell, just after completing an action, whether it was impulsive (there being no time to decide) and when there was time to deliberate (the participant decided to allow/not to veto the action). The study found evidence that subjects could not tell this important difference. This again leaves some conceptions of free will vulnerable to the introspection illusion. The researchers interpret their results to mean that the decision to "veto" an action is determined subconsciously, just as the initiation of the action may have been subconscious in the first place.[56]

The experiment involved asking volunteers to respond to a go-signal by pressing an electronic "go" button as quickly as possible.[56] In this experiment the go-signal was represented as a visual stimulus shown on a monitor (e.g. a green light as shown on the picture). The participants' reaction times (RT) were gathered at this stage, in what was described as the "primary response trials".

The primary response trials were then modified, in which 25% of the go-signals were subsequently followed by an additional signal either a "stop" or "decide" signal. The additional signals occurred after a "signal delay" (SD), a random amount of time up to 2 seconds after the initial go-signal. They also occurred equally, each representing 12.5% of experimental cases. These additional signals were represented by the initial stimulus changing colour (e.g. to either a red or orange light). The other 75% of go-signals were not followed by an additional signal and was therefore considered the "default" mode of the experiment. The participants' task of responding as quickly as possible to the initial signal (i.e. pressing the "go" button) remained.

Upon seeing the initial go-signal, the participant would immediately intend on pressing the "go" button. The participant was instructed to cancel their immediate intention to press the "go" button if they saw a stop signal. The participant was instructed to select randomly (at their leisure) between either pressing the "go" button, or not pressing it, if they saw a decide signal. Those trials in which the decide signal was shown after the initial go-signal ("decide trials"), for example, required that the participants prevent themselves from acting impulsively on the initial go-signal and then decide what to do. Due to the varying delays, this was sometimes impossible (e.g. some decide signals simply appeared too late in the process of them both intending to and pressing the go button for them to be obeyed).

Those trials in which the subject reacted to the go-signal impulsively without seeing a subsequent signal show a quick RT of about 600ms. Those trials in which the decide signal was shown too late, and the participant had already enacted their impulse to press the go-button (i.e. had not decided to do so), also show a quick RT of about 600ms. Those trials in which a stop signal was shown and the participant successfully responded to it, do not show a response time. Those trials in which a decide signal was shown, and the participant decided not to press the go-button, also do not show a response time. Those trials in which a decide signal was shown, and the participant had not already enacted their impulse to press the go-button, but (in which it was theorised that they) had had the opportunity to decide what to do, show a comparatively slow RT, in this case closer to 1400ms.[56]

The participant was asked at the end of those "decide trials" in which they had actually pressed the go-button whether they had acted impulsively (without enough time to register the decide signal before enacting their intent to press the go-button in response to the initial go-signal stimulus), or had acted based upon a conscious decision made after seeing the decide signal. Based upon the response time data however, it appears there was discrepancy between when the user thought they had had the opportunity to decide (and had therefore not acted on their impulses) - in this case deciding to press the go-button, and when they thought they had acted impulsively (based upon the initial go-signal) - where the decide signal came too late to be obeyed.

Kuhn and Brass wanted to test participant self-knowledge. The first step was that after every decide trial, participants were next asked whether they had actually had time to decide. Specifically, the volunteers were asked to label each decide trial as either failed-to-decide (the action was the result of acting impulsively on the initial go-signal) or successful decide (the result of a deliberated decision). See the diagram on the right for this decide trial split: failed-to-decide and successful decide; the next split in this diagram (participant correct or incorrect) will be explained at the end of this experiment. Note also that the researchers sorted the participants successful decide trials into "decide go" and "decide nogo", but were not concerned with the nogo trials since they did not yield any RT data (and are not featured anywhere in the diagram on the right). Note that successful stop trials did not yield RT data either.

Kuhn and Brass now knew what to expect: primary response trials, any failed stop trials, and the "failed-to-decide" trials were all instances where the participant obviously acted impulsively they would show the same quick RT. In contrast, the "successful decide" trials (where the decision was a "go" and the subject moved) should show a slower RT. Presumably, if deciding whether to veto is a conscious process, volunteers should have no trouble distinguishing impulsivity from instances of true deliberate continuation of a movement. Again, this is important since decide trials require that participants rely on self-knowledge. Note that stop trials cannot test self-knowledge because if the subject does act, it is obvious to them that they reacted impulsively.[56]

Unsurprisingly, the recorded RTs for the primary response trials, failed stop trials, and "failed-to-decide" trials all showed similar RTs: 600ms seems to indicate an impulsive action made without time to truly deliberate. What the two researchers found next was not as easy to explain: while some "successful decide" trials did show the tell-tale slow RT of deliberation (averaging around 1400ms), participants had also labelled many impulsive actions as "successful decide". This result is startling because participants should have had no trouble identifying which actions were the results of a conscious "I will not veto", and which actions were un-deliberated, impulsive reactions to the initial go-signal. As the authors explain:

In decide trials the participants, it seems, were not able to reliably identify whether they had really had time to decide at least, not based on internal signals. The authors explain that this result is difficult to reconcile with the idea of a conscious veto, but simple to understand if the veto is considered an unconscious process.[56] Thus it seems that the intention to move might not only arise from the subconscious, but it may only be inhibited if the subconscious says so. This conclusion could suggest that the phenomenon of "consciousness" is more of narration than direct arbitration (i.e. unconscious processing causes all thoughts, and these thoughts are again processed subconsciously).

After the above experiments, the authors concluded that subjects sometimes could not distinguish between "producing an action without stopping and stopping an action before voluntarily resuming", or in other words, they could not distinguish between actions that are immediate and impulsive as opposed to delayed by deliberation.[56] To be clear, one assumption of the authors is that all the early (600ms) actions are unconscious, and all the later actions are conscious. These conclusions and assumptions have yet to be debated within the scientific literature or even replicated (it is a very early study).

The results of the trial in which the so-called "successful decide" data (with its respective longer time measured) was observed may have possible implications[clarification needed] for our understanding of the role of consciousness as the modulator of a given action or response and these possible implications cannot merely be omitted or ignored without valid reasons, specially when the authors of the experiment suggest that the late decide trials were actually deliberated.[56]

It is worth noting that Libet consistently referred to a veto of an action that was initiated endogenously.[45] That is, a veto that occurs in the absence of external cues, instead relying on only internal cues (if any at all). This veto may be a different type of veto than the one explored by Khn and Brass using their decide signal.

Daniel Dennett also argues that no clear conclusion about volition can be derived from Benjamin Libet's experiments supposedly demonstrating the non-existence of conscious volition. According to Dennett, ambiguities in the timings of the different events involved. Libet tells when the readiness potential occurs objectively, using electrodes, but relies on the subject reporting the position of the hand of a clock to determine when the conscious decision was made. As Dennett points out, this is only a report of where it seems to the subject that various things come together, not of the objective time at which they actually occur.

Suppose Libet knows that your readiness potential peaked at millisecond 6,810 of the experimental trial, and the clock dot was straight down (which is what you reported you saw) at millisecond 7,005. How many milliseconds should he have to add to this number to get the time you were conscious of it? The light gets from your clock face to your eyeball almost instantaneously, but the path of the signals from retina through lateral geniculate nucleus to striate cortex takes 5 to 10 milliseconds a paltry fraction of the 300 milliseconds offset, but how much longer does it take them to get to you. (Or are you located in the striate cortex?) The visual signals have to be processed before they arrive at wherever they need to arrive for you to make a conscious decision of simultaneity. Libet's method presupposes, in short, that we can locate the intersection of two trajectories:

In early 2016, PNAS published a paper by researchers in Berlin, Germany, The point of no return in vetoing self-initiated movements, in which the authors set out to investigate whether human subjects had the ability to veto an action (in this study, a movement of the foot) after the detection of its Bereitschaftspotential (BP).[59] The Bereitschaftspotential, which was discovered by Kornhuber & Deecke in 1965,[28] is an instance of unconscious electrical activity within the motor cortex, quantified by the use of EEG, that occurs moments before a motion is performed by a person: it is considered a signal that the brain is "getting ready" to perform the motion. The study found evidence that these actions can be vetoed even after the BP is detected (i. e. after it can be seen that the brain has started preparing for the action). The researchers maintain this is evidence for the existence of at least some degree of free will in humans:[60] previously, it had been argued[61] that, given the unconscious nature of the BP and its usefulness in predicting a person's movement, these are movements that are initiated by the brain without the involvement of the conscious will of the person.[62][63] The study showed that subjects were able to "override" these signals and stop short of performing the movement that was being anticipated by the BP. Furthermore, researchers identified what was termed a "point of no return": once the BP is detected for a movement, the person could refrain from performing the movement only if they attempted to cancel it 200 milliseconds or longer before the onset of the movement. After this point, the person was unable to avoid performing the movement. Previously, Kornhuber & Deecke underlined that absence of conscious will during the early Bereitschaftspotential (termed BP1) is not a proof of the non-existence of free will, as also unconscious agendas may be free and non-deterministic. According to their suggestion, man has relative freedom, i.e. freedom in degrees, that can be in- or decreased through deliberate choices that involve both conscious and unconscious (panencephalic) processes.[64]

Despite criticisms, experimenters are still trying to gather data that may support the case that conscious "will" can be predicted from brain activity. fMRI machine learning of brain activity (multivariate pattern analysis) has been used to predict the user choice of a button (left/right) up to 7 seconds before their reported will of having done so.[5] Brain regions successfully trained for prediction included the frontopolar cortex (anterior medial prefrontal cortex) and precuneus/posterior cingulate cortex (medial parietal cortex). In order to ensure report timing of conscious "will" to act, they showed the participant a series of frames with single letters (500ms apart), and upon pressing the chosen button (left or right) they were required to indicate which letter they had seen at the moment of decision. This study reported a statistically significant 60% accuracy rate, which may be limited by experimental setup; machine learning data limitations (time spent in fMRI) and instrument precision.

Another version of the fMRI multivariate pattern analysis experiment was conducted using an abstract decision problem, in an attempt to rule out the possibility of the prediction capabilities being product of capturing a built-up motor urge.[65] Each frame contained a central letter like before, but also a central number, and a surrounding 4 possible "answers numbers". The participant first chose in their mind whether they wished to perform an addition or difference operation (and noted the central letter on the screen at the time of this decision). The participant then performed the mathematical operation based on the central numbers shown in the next two frames. In the following frame the participant then chose the "answer number" corresponding to the result of the operation. They were further presented with a frame which allowed them to indicate the central letter appearing on the screen at the time of their original decision. This version of the experiment discovered a brain prediction capacity of up to 5 seconds before the conscious will to act.

Multivariate pattern analysis using EEG has suggested that an evidence based perceptual decision model may be applicable to free will decisions.[66] It was found that decisions could be predicted by neural activity immediately after stimulus perception. Furthermore, when the participant was unable to determine the nature of the stimulus the recent decision history predicted the neural activity (decision). The starting point of evidence accumulation was in effect shifted towards a previous choice (suggesting a priming bias). Another study has found that subliminally priming a participant for a particular decision outcome (showing a cue for 13ms) could be used to influence free decision outcomes.[67] Likewise, it has been found that decision history alone can be used to predict future decisions. The prediction capacities of the Soon et al. (2008) experiment were successfully replicated using a linear SVM model based on participant decision history alone (without any brain activity data).[68] Despite this, a recent study has sought to confirm the applicability of a perceptual decision model to free will decisions.[69] When shown a masked and therefore invisible stimulus, participants were asked to either guess between a category or make a free decision for a particular category. Multivariate pattern analysis using fMRI could be trained on "free decision" data to successfully predict "guess decisions", and trained on "guess data" in order to predict "free decisions" (in the precuneus and cuneus region).

Contemporary voluntary decision prediction tasks have been criticised based on the possibility the neuronal signatures for pre-conscious decisions could actually correspond to lower conscious processing rather than unconscious processing.[70] People may be aware of their decisions before making their report yet need to wait several seconds to be certain. Such a model does not however explain what is left unconscious if everything can be conscious at some level (and the purpose of defining separate systems). Yet limitations remain in free will prediction research to date. In particular, the prediction of considered judgements from brain activity involving thought processes beginning minutes rather than seconds before a conscious will to act, including the rejection of a conflicting desire. Such are generally seen to be the product of sequences of evidence accumulating judgements.

It has been suggested that sense authorship is an illusion.[71] Unconscious causes of thought and action might facilitate thought and action, while the agent experiences the thoughts and actions as being dependent on conscious will. We may over-assign agency because of the evolutionary advantage that once came with always suspecting there might be an agent doing something (e.g. predator). The idea behind retrospective construction is that, while part of the "yes, I did it" feeling of agency seems to occur during action, there also seems to be processing performed after the fact - after the action is performed - to establish the full feeling of agency.[72]

Unconscious agency processing can even alter, in the moment, how we perceive the timing of sensations or actions.[42][44] Khn and Brass apply retrospective construction to explain the two peaks in "successful decide" RT's. They suggest that the late decide trials were actually deliberated, but that the impulsive early decide trials that should have been labelled "failed to decide" were mistaken during unconscious agency processing. They say that people "persist in believing that they have access to their own cognitive processes" when in fact we do a great deal of automatic unconscious processing before conscious perception occurs.

It should be noted that criticism to Wegner's claims regarding the significance of introspection illusion for the notion of free will has been published.[73]

Some research suggests that TMS can be used to manipulate the perception of authorship of a specific choice.[74] Experiments showed that neurostimulation could affect which hands people move, even though the experience of free will was intact. An early TMS study revealed that activation of one side of the neocortex could be used to bias the selection of one's opposite side hand in a forced-choice decision task.[75] Ammon and Gandevia found that it was possible to influence which hand people move by stimulating frontal regions that are involved in movement planning using transcranial magnetic stimulation in the left or right hemisphere of the brain.

Right-handed people would normally choose to move their right hand 60% of the time, but when the right hemisphere was stimulated they would instead choose their left hand 80% of the time (recall that the right hemisphere of the brain is responsible for the left side of the body, and the left hemisphere for the right). Despite the external influence on their decision-making, the subjects continued to report that they believed their choice of hand had been made freely. In a follow-up experiment, Alvaro Pascual-Leone and colleagues found similar results, but also noted that the transcranial magnetic stimulation must occur within 200 milliseconds, consistent with the time-course derived from the Libet experiments.[76]

In late 2015, a team of researchers from the UK and the US published a paper demonstrating similar findings. The researchers concluded that "motor responses and the choice of hand can be modulated using tDCS".[77] However, a different attempt by Sohn et al. failed to replicate such results;[78] later, Jeffrey Gray wrote in his book Consciousness: Creeping up on the Hard Problem that tests looking for the influence of electromagnetic fields on brain function have been universally negative in their result.[79]

Various studies indicate that the perceived intention to move (have moved) can be manipulated. Studies have focused on the pre-supplementary motor area (pre-SMA) of the brain, in which readiness potential indicating the beginning of a movement genesis has been recorded by EEG. In one study, directly stimulating the pre-SMA caused volunteers to report a feeling of intention, and sufficient stimulation of that same area caused physical movement.[42] In a similar study, it was found that people with no visual awareness of their body can have their limbs be made to move without having any awareness of this movement, by stimulating premotor brain regions.[80] When their parietal cortices were stimulated, they reported an urge (intention) to move a specific limb (that they wanted to do so). Furthermore, stronger stimulation of the parietal cortex resulted in the illusion of having moved without having done so.

This suggests that awareness of an intention to move may literally be the "sensation" of the body's early movement, but certainly not the cause. Other studies have at least suggested that "The greater activation of the SMA, SACC, and parietal areas during and after execution of internally generated actions suggests that an important feature of internal decisions is specific neural processing taking place during and after the corresponding action. Therefore, awareness of intention timing seems to be fully established only after execution of the corresponding action, in agreement with the time course of neural activity observed here."[81]

Another experiment involved an electronic ouija board where the device's movements were manipulated by the experimenter, while the participant was led to believe they were entirely self-conducted.[82] The experimenter stopped the device on occasions and asked the participant how much they themselves felt like they wanted to stop. The participant also listened to words in headphones; and it was found that if experimenter stopped next to an object that came through the headphones they were more likely to say they wanted to stop there. If the participant perceived having the thought at the time of the action, then it was assigned as intentional. It was concluded that a strong illusion of perception of causality requires; priority (we assume the thought must precede the action), consistency (the thought is about the action), and exclusivity (no other apparent causes or alternative hypotheses).

Lau et al. set up an experiment where subjects would look at an analogue-style clock, and a red dot would move around the screen. Subjects were told to click the mouse button whenever they felt the intention to do so. One group was given a transcranial magnetic stimulation (TMS) pulse, and the other was given a sham TMS. Subjects in the intention condition were told to move the cursor to where it was when they felt the inclination to press the button. In the movement condition, subjects moved their cursor to where it was when they physically pressed the button. Results showed the TMS was able to shift the perceived intention forward by 16ms, and shifted back the 14ms for the movement condition. Perceived intention could be manipulated up to 200ms after the execution of the spontaneous action, indicating that the perception of intention occurred after the executive motor movements.[44] Often it is thought that free will were to exist, it would require intention to be the causal source of behavior. These results show that intention may not be the causal source of all behavior.

The idea that intention co-occurs with (rather than causes) movement is reminiscent of "forward models of motor control" (or FMMC, which have been used to try to explain inner speech). FMMCs describe parallel circuits: movement is processed in parallel with other predictions of movement; if the movement matches the prediction - the feeling of agency occurs. FMMCs have been applied in other related experiments. Metcalfe and her colleagues used an FMMC to explain how volunteers determine whether they are in control of a computer game task. On the other hand, they acknowledge other factors too. The authors attribute feelings of agency to desirability of the results (see self serving biases) and top-down processing (reasoning and inferences about the situation).[83]

In this case, it is by the application of the forward model that one might imagine how other consciousness processes could be the result of efferent, predictive processing. If the conscious self is the efferent copy of actions and vetoes being performed, then the consciousness is a sort of narrator of what is already occurring in the body, and an incomplete narrator at that. Haggard, summarizing data taken from recent neuron recordings, says "these data give the impression that conscious intention is just a subjective corollary of an action being about to occur".[11][12] Parallel processing helps explain how we might experience a sort of contra-causal free will even if it were determined.

How the brain constructs consciousness is still a mystery, and cracking it open would have a significant bearing on the question of free will. Numerous different models have been proposed, for example, the Multiple Drafts Model which argues that there is no central Cartesian theater where conscious experience would be represented, but rather that consciousness is located all across the brain. This model would explain the delay between the decision and conscious realization, as experiencing everything as a continuous 'filmstrip' comes behind the actual conscious decision. In contrast, there exist models of Cartesian materialism that have gained recognition by neuroscience, implying that there might be special brain areas that store the contents of consciousness; this does not, however, rule out the possibility of a conscious will. Other models such as epiphenomenalism argue that conscious will is an illusion, and that consciousness is a by-product of physical states of the world. Work in this sector is still highly speculative, and researchers favor no single model of consciousness. (See also: Philosophy of mind.)

Although humans clearly make choices, the role of consciousness (at least, when it comes to motor movements) may need re-conceptualization. Only one thing is certain: the correlation of a conscious "intention to move" with a subsequent "action" does not guarantee causation. Recent studies cast doubt on such a causal relation, and so more empirical data is required.

Various brain disorders implicate the role of unconscious brain processes in decision making tasks. Auditory hallucinations produced by Schizophrenia seem to suggest a divergence of will and behaviour.[71] The left brain of people whose hemispheres have been disconnected has been observed to invent explanations for body movement initiated by the opposing (right) hemisphere, perhaps based on the assumption that their actions are consciously willed.[84] Likewise, people with 'alien hand syndrome' are known to conduct complex motor movements against their will.[85]

A neural model for voluntary action proposed by Haggard comprises two major circuits.[42] The first involving early preparatory signals (basal ganglia substantia nigra and striatum), prior intention and deliberation (medial prefrontal cortex), motor preparation/readiness potential (preSMA and SMA), and motor execution (primary motor cortex, spinal cord and muscles). The second involving the parietal-pre-motor circuit for object-guided actions, for example grasping (premotor cortex, primary motor cortex, primary somatosensory cortex, parietal cortex, and back to the premotor cortex). He proposed that voluntary action involves external environment input ('when decision'), motivations/reasons for actions (early 'whether decision'), task and action selection ('what decision'), a final predictive check (late 'whether decision') and action execution.

Another neural model for voluntary action also involves what, when, and whether (WWW) based decisions.[86] The 'what' component of decisions is considered a function of the anterior cingulate cortex, which is involved in conflict monitoring.[87] The timing ('when') of the decisions are considered a function of the preSMA and SMA, which is involved in motor preparation.[88] Finally, the 'whether' component is considered a function of the dorsal medial prefrontal cortex.[86]

Martin Seligman and others criticize the classical approach in science which views animals and humans as "driven by the past", and suggest instead that people and animals draw on experience to evaluate prospects they face, and act accordingly. The claim is made that this purposive action includes evaluation of possibilities that have never occurred before, and is experimentally verifiable.[89][90]

Seligman and others argue that free will and the role of subjectivity in consciousness can be better understood by taking such a "prospective" stance on cognition, and that "accumulating evidence in a wide range of research suggests [this] shift in framework".[90]

Continued here:
Neuroscience of free will - Wikipedia

Vaccines Conferences | Immunology Conferences | World …

Conference Series LLClook forward to welcoming all the participants across the globe to attend19thEuro Global Summit and Expo on Vaccines & Vaccinationgoing to be held duringJune 19-21, 2016 in Paris, France. The conference highlights the theme Accelerating Next Generation Vaccines for Global Health covering all important aspects in Vaccines and therapeutics.

Euro Vaccines 2017conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.

Track 1:Human Vaccines - Infectious & Non Infectious Diseases

Avaccineis an inactivated form of bacteria or virus that is injected into the body to simulate an actualinfection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate animmune responseby the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate theimmune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 2:Vaccine Research & Development:

Vaccine Developmentis an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedentedEbola diseaseoutbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 3:Cancer Vaccines:

Immunotherapeuticsis treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:

Some types ofimmunotherapyare also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and theyll impact how we treat cancer in the future.

Immunotherapy includes treatments that work in different ways. Some boost the bodys immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. Its used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro GlobalSummit on Cancer Therapy, Sept 26-28, 2016, UK; InternationalConference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World;Vaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 4:HIV Vaccines:

AnAIDSvaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A preventive vaccine would stopHIV infectionoccurring altogether, whereas a therapeutic vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind allHIV vaccinesis to encourage the humanimmune systemto fight HIV.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; AnnualConference on Virulent HIV Vaccines, July 28-30, 2016 Thailand; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; HIV Research for Prevention 2016, 17-21 October, Chicago, USA; InternationalAIDS Conference2016, July 17-19, 2016, Durban, South Africa;HIV Trials Network Meeting, MAY 18-20, 2016, Washington D.C., USA;HIV Vaccines(X8), March 2024, 2016, California, USA;HIV Research for Prevention2016 (HIVR4P), October 17- 20, 2016, Chicago, USA

Track 5:Vaccines safety& Efficacy:

Vaccines are the best defense we have against serious, preventable, and sometimes deadlycontagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may behealth risk. Accurate information about the value of vaccines as well as their possibleside-effectshelps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 6:Vaccination for Pregnant Women:

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning apregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you.Tetanus/Diphtheria/Pertussis(Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Pregnancy Summit& Child Health, Aug 29-31, 2016, Brazil; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 7:Childhood Vaccines:

Vaccinationgiven to children is called childrenImmunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system orneurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.

We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. Thats why its important that children, especially infants and young children receive recommended immunizations on time.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Track 8:Vaccine Adjuvants & Delivery Technologies:

Vaccine adjuvants - is an ingredient of a vaccine that helps create a stronger immune response in the patients body. In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protectiveimmune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s. Small amounts of aluminum are added to help the body build strongerimmunityagainst the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Drug deliverysystems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug deliverysuch as transport in the circulatory system and drug movement through cells and tissuesthey have contributed to the development of a number of new modes of drug delivery that have entered clinical practice. Role of vaccine delivery technologies includes rational development of vaccines, achievingimmunizationgoals, supporting best clinical practice.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 8th InternationalConference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 7-9, 2016, Spain; 9th WorldDrug Delivery Summit, June 30-July 2, 2016, USA; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE;Drug Delivery CongressEurope, Germany; 13th Annual InternationalNanomedicine and Drug Delivery Symposium, USA;Vaccines for Children & Vaccine Preventable Disease ConferenceSouth Iselin, NJ; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA

Track 9:Immunization for Older Adults:

Vaccines are an important part of routine preventive care for older adults, but most adults dont get their vaccines as recommended. Omittingvaccinationleaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death frominfectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Geriatric Medicine Conference, Nov 17-19, 2016, USA; 3rd InternationalConference on Geriatrics & Gerontology, Aug 15-17, 2016, UK; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 10:Vaccines against Viral and Bacterial Diseases:

Most vaccines againstviral infectionare effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.

It is difficult for many of us today to appreciate the dangers of childhood viral infections.

Most of the vaccines in use againstvirusesare very effective at preventingdisease. However, for a variety of reasons, they can fail:

The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.

Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.

Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available againsttuberculosis,diphtheria,tetanus,pertussis, Haemophilus influenzae type B,cholera, typhoid, and Streptococcus pneumoniae.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia;Vaccine Summit, UK; BIT's 6th AnnualWorld Congress of Vaccine, China; 9thVaccines & ISV Congress, South Korea; WorldVaccines Congress, USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 2ndAntivirals CongressMassachusetts, United States;Vaccinology conferenceSydney Australia;Vaccines R&D conference-2015 A New Era in Vaccine Discovery Baltimore, USA; MoldovaVaccine Summit, UK;Immunotherapy and Vaccine SummitBoston, USA

Track 11:DNA Vaccines:

DNA vaccinationis a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

Vaccinationconsists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime theimmune system.

The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing theimmune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Track 12:HPV Vaccines:

Human Papillomavirus (HPV)vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.

These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.

RoutineHPV Vaccination

It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV. For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Human Papillomavirus, May 2-3, 2016, USA; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Track 13:Tuberculosis Vaccines:

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculousmeningitisand miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection withMycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccines potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; The 2016TB Summit: 21 23 June 2016, London, UK;EMBO conference Tuberculosis2016, September 19-23, 2016, Paris, France; 20th AnnualTB Conference, February 24-27, 2016, Colorado, USA; ICTT 2016 : 18th InternationalConference on Tuberculosis Therapy, February 25 - 26, 2016, London, United Kingdom; 47th Union WorldConference on Lung Health, 25-29 October 2016, Liverpool, UK; Joint 20thConference of The Union North America Region and the National TB Controllers Association, 24-27 February 2016, Colorado, USA

Track 14:Mucosal vaccines:

Mostinfectious agentsenter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosalimmune system(dispersed or organised into units such as Peyers patches in the intestine or the nasal-associated lymphoidtissuein the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Track 15:Vaccines for Vector-borne Diseases:

Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens.Vector-borne diseasesare among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.

Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.Malariawas driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.

In contrast to expenditure and effort on medicine, diagnostic andvaccine development, relatively little attention was given to vector control in the past. The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro GlobalSummit on Cancer Therapy, Sept 26-28, 2016, UK; InternationalConference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 16:Human Preventive& Therapeutic Vaccines:

Apreventative vaccineis administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases likepolio,chicken pox,measles, mumps, rubella,influenza(flu), and hepatitis A and B.

In addition to preventive vaccines, there are also therapeutic vaccines. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as therapeutic immunogens.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 17:Plant-based vaccines:

Plant-basedvaccinesare recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oraldrug deliveryin the form of an edible vaccine. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, andanimal vaccineprojects have given promising data in early phase trials targeting specific animal species.

The plant-based vaccine production method works by isolating a specific antigen protein, one that triggers a humanimmune responsefrom the targeted virus. A gene from the protein is transferred to bacteria, which are then used to infect plant cells. The plants then start producing the exact protein that will be used for vaccinations. The flexibility of the plant expressed vaccine system, combined with its low cost and ability to massively scale may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines. Other uses of plant expressed vaccines including the successful creation of edible bananas that protect against the Norwalk virus.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Track 18: Veterinary vaccines:

Veterinary vaccinesare to improve the health and welfare of companion animals, increase production of livestockin a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally.Oral rabies vaccinesare widely used in foxes in Europe and in racoons in the USA.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Read the original post:
Vaccines Conferences | Immunology Conferences | World ...